Incyte (INCY) Net Equity Issued and Repurchased (2010 - 2011)

Incyte's (INCY) quarterly Net Equity Issued and Repurchased came in at $1.1 million in Q3 2011, down 68.28% YoY from $3.4 million in Q3 2010, and down 91.42% on a QoQ basis from $12.5 million in Q2 2011.

Incyte (INCY) Net Equity Issued and Repurchased (2010 - 2011) Analysis & Trends

Incyte (INCY) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $1.1 million in Q3 2011.

  • Quarterly Net Equity Issued and Repurchased fell 68.28% year-over-year to $1.1 million in Q3 2011, while the trailing twelve-month figure through Dec 2017 was $17.7 million (changed N/A YoY) and the FY2017 annual result came in at $649.4 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased slipped to $1.1 million in Q3 2011, from $12.5 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $12.5 million in Q2 2011 to a low of $1.1 million in Q3 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 49.20 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn -
4 Revolution Medicines 43.64 Bn 43.64 Bn - 141.90 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn -
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn -
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn -
10 Incyte 24.15 Bn 19.61 Bn 1.57 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2011 1.07 Mn
Sep 30, 2011 1.07 Mn
Jun 30, 2011 12.51 Mn
Jun 30, 2011 12.51 Mn
Mar 31, 2011 4.13 Mn
Mar 31, 2011 4.13 Mn
Sep 30, 2010 3.38 Mn
Sep 30, 2010 3.38 Mn
Jun 30, 2010 2.43 Mn
Jun 30, 2010 2.43 Mn
Mar 31, 2010 4.23 Mn
Mar 31, 2010 4.23 Mn